Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 915-371-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
OECD 423: Acute Oral LD50(Rat) > 2000 mg/Kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 04 June 2018 - 28 August 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- 17 Dec 2001
- Deviations:
- yes
- Remarks:
- Deviations were considered not to adversely affect the results of or integrity of the study.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Version / remarks:
- 20 May 2008
- Deviations:
- not specified
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Version / remarks:
- 712-C-98-190 (1998)
- Deviations:
- not specified
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
- Specific details on test material used for the study:
- Test Item: Reaction mass of 3-(4-methyl-3-pentenyl)cyclohex-3-ene1-carbonitrile and 4-(4-methyl-3-pentenyl)cyclohex-3-ene1-carbonitrile
Public name: Azuril
EC number: 915-371-2
CAS number: n/a
Batch/lot number: A170421E
Description: Clear, pale yellow liquid
Expiry date: 06 June 2019
Purity: 99.35%
Storage conditions: Room temperature (15-25 °C, ≤70 RH%), under inert gas, protected from humidity (tight closed container)
Identification of test item: The identification of the test item was made in the Pharmacy of Citoxlab Hungary Ltd. on the basis of the information provided by Sponsor.
Treatment of test material prior to testing: The test item was freshly formulated at a concentration of 200 mg/mL in the vehicle, in the Pharmacy of Citoxlab Hungary Ltd. on the day of administration. The formulation container was magnetic stirred continuously up to the end of dose administration procedures. - Species:
- rat
- Strain:
- Wistar
- Remarks:
- Crl:WI
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
Crl:WI Wistar rats
Sex: female
Females nulliparous and non-pregnant: yes
Age at study initiation: 8 weeks
Weight at study initiation: 202-210 g
Fasting period before study: overnight, food returned 3 h after treatment
Diet: ad libitum - ssniff® SM R/M Autoclavable complete diet for rats and mice – breeding and maintenance
Water: ad libitum – tap water used for human consumption
Acclimation period: 7-8 days
Housing: group caging (3 rats/cage)
Source: Charles River Laboratories, Research Models and Services, Germany GmbH, Sandhofer Weg 7, D-97633 Sulzfeld, Germany
ENVIRONMENTAL CONDITIONS
Temperature (°C): 20.2 – 25.0
Humidity (%): 40 – 79
Air changes (per hr): 15-20
Photoperiod (hrs dark / hrs light): 12/12
Treatment: 05/06 June 2018
Observation: 05/06 June – 19 June 2018
Necropsy: 19/20 June 2018
- Route of administration:
- oral: gavage
- Vehicle:
- other: PEG 400 (polyethylene glycol 400)
- Details on oral exposure:
- VEHICLE: PEG 400
- Concentration in vehicle: 200 mg/mL of test material in the vehicle
- Justification for choice of vehicle: The selection of PEG 400 was made during trial formulations with the test item. Vehicles tested in trial formulations were distilled water, 1% methyl cellulose solution, corn oil, PEG 400 and propylene glycol. Corn oil and PEG 400 resulted in visibly clear solutions, other formulations were not visibly homogenous. PEG 400 (polyethylene glycol 400) was selected for this study and for the upcoming repeated dose rat studies, because it is more adapted to the chemical analytical methods to be used. In addition, PEG 400 is frequently used vehicle in rodent toxicological studies due to its well known characteristics and low toxicity (Gad et al. 2016. Int J Toxicol 35, 95-178).
- Lot/batch no: A0378559
- Purity: NA
- Expiry Date: 30 November 2021
- Dose volume: 10 mL/kg bw
CLASS METHOD
- Three female rats were treated with the limit dose 2000 mg/kg bw of the test item. No mortality was observed, therefore further 3 animals were treated at the dose level of 2000 mg/kg bw. As no mortality was observed in this second dose group, further testing was not required according to the test guidelines. The dose of 2000 mg/kg bw was considered acceptable. - Doses:
- Step 1: 2000 mg/kg bw
Step 2: 2000 mg/kg bw - No. of animals per sex per dose:
- Step 1: 3
Step 2: 3
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: 30 minutes, 1, 2, 3, 4 and 6 hours after dosing and daily
- Necropsy of survivors performed: yes
- Other examinations performed: Individual observations were performed on the skin, fur, eyes, mucous membranes, respiratory, circulatory, autonomic and central nervous system, somatomotor activity and behaviour pattern. Particular attention was directed to observation of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma. Body weight was recorded on the day before treatment (Day -1), on the day of the treatment (Day 0), weekly thereafter and at necropsy (Day 14). - Preliminary study:
- Three female animals were treated with 2000 mg/kg bw of the test item (step 1). No mortality was observed, therefore further 3 animals were treated at the dose level of 2000 mg/kg bw (step 2).
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- The test item did not cause mortality.
- Clinical signs:
- other: No evidence of adverse clinical signs observed.
- Gross pathology:
- No evidence of macroscopic changes observed during necropsy.
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- The LD50 for acute oral toxicity of the test material Azuril (Reaction mass of 3-(4-methyl-3-pentenyl)cyclohex3-ene-1-carbonitrile and 4-(4-methyl-3pentenyl)cyclohex-3-ene-1-carbonitrile) was found to be above 2000 mg/kg bw in female Crl:WI Wistar rats. According to the GHS criteria, classification of the test item can be ranked as "Category 5 or Unclassified" for acute oral exposure.
- Executive summary:
The aim of this study was to evaluate the acute oral (gavage) toxicity potential of the test material Azuril [Reaction mass of 3-(4-methyl-3-pentenyl)cyclohex3-ene-1-carbonitrile and 4-(4-methyl-3pentenyl)cyclohex-3-ene-1-carbonitrile].
The limit test using the dose of 2000 mg/kg bw was performed with totally six female Crl:WI Wistar rats. For the first step, three rats were treated without mortality. Therefore, a second group of three female rats was treated at the same dose level. No further testing was required, as no mortality was observed at 2000 mg/kg bw. PEG 400 (polyethylene glycol 400) was selected as a vehicle for this study.
Clinical observations were performed at 30 minutes, 1, 2, 3, 4 and 6 hours after dosing and daily for 14 days thereafter. Body weights were measured on days -1, 0, 7 and before necropsy (day 14). No mortality was observed, and body weight values were in the normal ranges. No evidence of the macroscopic changes was observed during the necropsy.
In conclusion, the acute oral LD50 value of the test item, Azuril (Reaction mass of 3-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carbonitrile and 4-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carbonitrile) was found to be above 2000 mg/kg bw in female Crl:WI Wistar rats.
According to the GHS criteria, classification of the test item can be ranked as "Category 5 or Unclassified" for acute oral exposure.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The acute oral (gavage) toxicity potential of the test material Azuril (Reaction mass of 3-(4-methyl-3-pentenyl)cyclohex3-ene-1-carbonitrile and 4-(4-methyl-3pentenyl)cyclohex-3-ene-1-carbonitrile) was evaluated according to the OECD 423 test guideline and under GLP conditions.
Two groups of three female Crl:WI rats were treated with the test item at a dose level of 2000 mg/kg body weight. Clinical observations were performed at 30 minutes, 1, 2, 3, 4 and 6 hours after dosing and daily for 14 days thereafter. Body weights were measured on Days -1, 0, 7 and before necropsy (Day 14). The body weight values were in the normal ranges and there was no evidence of the macroscopic changes observed. No further testing was required,
as no mortality was observed at 2000 mg/kg bw. PEG 400 (polyethylene glycol 400) was used as a vehicle.
In conclusion, the acute oral LD50 value of the test item, Azuril (Reaction mass of 3-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carbonitrile and 4-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carbonitrile) was found to be above 2000 mg/kg bw in female Crl:WI Wistar rats. According the GHS criteria, classification of the test item can be ranked as "Category 5 or Unclassified" for acute oral exposure.
Justification for classification or non-classification
Reaction mass of 3-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carbonitrile and 4-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carbonitrile (Azuril) does not meet the criteria to be classified for acute oral toxicity under EU Regulation (EC) No 1272/2008 (CLP). However, according to the GHS criteria, based on an oral LD50of >2000 mg/Kg bw, the test material can be classified as "Category 5" or “Unclassified” for acute oral exposure.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.